Biotech CEO, Recovering Classical Pianist, Long-distance runner, Krav Maga and Boxing enthusiast, Amateur Chef, and major Foodie. All opinions are mine alone.
vTv announces a $51 Million Private Placement with leading, healthcare-focused institutional investors and the JDRF T1D Fund, which will fund the first p3 study of cadisegliatin as an adjunctive therapy to insulin.
Full release here: https://t.co/PLhGNmr86K